SCHEMBL9419620

SCHEMBL9419620

OCCC1CN(CCCN2c3ccccc3Oc3ccccc32)CCN1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.45
SMPD1 P17405 1/20 0.41
CHRM1 P11229 7/20 0.41
DRD2 P14416 6/20 0.41
DRD3 P35462 5/20 0.41
CHRM2 P08172 4/20 0.41
KCNH2 Q12809 4/20 0.41
HTR1A P08908 3/20 0.41
ADRA2B P18089 3/20 0.41
ADRA2C P18825 3/20 0.41
SLC6A2 P23975 3/20 0.41
HTR2A P28223 3/20 0.41
SLC6A4 P31645 3/20 0.41
ADRA1A P35348 3/20 0.41
HRH1 P35367 3/20 0.41
SLC6A3 Q01959 3/20 0.41
ADRA2A P08913 2/20 0.41
DRD1 P21728 1/20 0.41
PTGS1 P23219 1/20 0.41
OPRM1 P35372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9419616 0.73 HTR1A (0.62) SIGMAR1CHRM1DRD2DRD3CHRM2
SCHEMBL13305256 0.73 KDM1A (0.61) SIGMAR1SMPD1CHRM1DRD2DRD3
SCHEMBL6102599 0.72 CACNA1B (0.51) SIGMAR1SMPD1CHRM1DRD2DRD3
SCHEMBL5051922 0.71 CA1 (0.39) SIGMAR1KMT2AMAPK1CYP1A2CA1
SCHEMBL6045244 0.70 PIM1 (0.41) SIGMAR1SMPD1MEN1KMT2AKDM1A
SCHEMBL6969785 0.70 CACNA1B (0.50) SIGMAR1SMPD1CHRM1DRD2DRD3
SCHEMBL6968853 0.70 DRD2 (0.54) SIGMAR1CHRM1DRD2DRD3CHRM2
SCHEMBL2016258 0.70 LTA4H (0.57) SIGMAR1MEN1KMT2ACYP3A4CYP1A2
SCHEMBL2019556 0.70 LTA4H (0.57) SIGMAR1MEN1KMT2ACYP3A4CYP1A2
SCHEMBL2016261 0.70 LTA4H (0.57) SIGMAR1MEN1KMT2ACYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5371081-A Useful in potentiating the cytotoxic effect of chemotherapeutic agents ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 1994-12-06 US claimed
WO-1993003729-A1 N-SUBSTITUTED PHENOXAZINES FOR TREATING MULTIDRUG RESISTANT CANCER CELLS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1993-03-04 WO claimed
US-5371081-A Useful in potentiating the cytotoxic effect of chemotherapeutic agents ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 1994-12-06 US disclosed
WO-1993003729-A1 N-SUBSTITUTED PHENOXAZINES FOR TREATING MULTIDRUG RESISTANT CANCER CELLS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1993-03-04 WO disclosed